Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Mayer

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Vnitrni Lekarstvi|June 22, 2012
[Vitamin D and cardiovascular risk]Otto Mayer
Casopis Lekaru Ceskych|August 3, 2016
[Matrix Gla protein as natural inhibitor of vascular calcification and potential treatment target]Otto Mayer
Vnitrni Lekarstvi|June 16, 2015
[In what extend we can reach the current LDL-cholesterol treatment goals in secondary prevention]Otto Mayer, Jan Bruthans,
Vnitrni Lekarstvi|October 15, 2015
[Usefulness of vena cava filters from clinicians view]Otto Mayer, Zdenka Poklopová
Vnitrni Lekarstvi|October 8, 2022
The mortality risk of patients hospitalized for ischemic stroke between 2003 and 2019Lenka Kielbergerová, Otto Mayer, Jan Bruthans
Journal of Cardiovascular Pharmacology|May 22, 2002
Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markersOtto Mayer, Jan Filipovský, Milan Hromádka, et al.
Biomarkers in Medicine|September 10, 2024
The long-term impact of increased red blood cell distribution width detected during hospitalization for heart failureOtto Mayer, Jan Bruthans, Josef Jirák, et al.
Kidney & Blood Pressure Research|December 24, 2023
The Prognostic Impact of Renal Function Decline during Hospitalization for Heart FailureOtto Mayer, Jan Bruthans, Simona Bílková, et al.
Vascular Health and Risk Management|February 28, 2007
Hypothyroidism in coronary heart disease and its relation to selected risk factorsOtto Mayer, Jaroslav Simon, Jan Filipovský, et al.
Vnitrni Lekarstvi|April 18, 2023
Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failureTomáš Krynský, Otto Mayer, Jan Bruthans, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Vnitrni Lekarstvi|June 22, 2012
[Vitamin D and cardiovascular risk]Otto Mayer
Casopis Lekaru Ceskych|August 3, 2016
[Matrix Gla protein as natural inhibitor of vascular calcification and potential treatment target]Otto Mayer
Vnitrni Lekarstvi|June 16, 2015
[In what extend we can reach the current LDL-cholesterol treatment goals in secondary prevention]Otto Mayer, Jan Bruthans,
Vnitrni Lekarstvi|October 15, 2015
[Usefulness of vena cava filters from clinicians view]Otto Mayer, Zdenka Poklopová
Vnitrni Lekarstvi|October 8, 2022
The mortality risk of patients hospitalized for ischemic stroke between 2003 and 2019Lenka Kielbergerová, Otto Mayer, Jan Bruthans
Journal of Cardiovascular Pharmacology|May 22, 2002
Treatment of hyperhomocysteinemia with folic acid: effects on homocysteine levels, coagulation status, and oxidative stress markersOtto Mayer, Jan Filipovský, Milan Hromádka, et al.
Biomarkers in Medicine|September 10, 2024
The long-term impact of increased red blood cell distribution width detected during hospitalization for heart failureOtto Mayer, Jan Bruthans, Josef Jirák, et al.
Kidney & Blood Pressure Research|December 24, 2023
The Prognostic Impact of Renal Function Decline during Hospitalization for Heart FailureOtto Mayer, Jan Bruthans, Simona Bílková, et al.
Vascular Health and Risk Management|February 28, 2007
Hypothyroidism in coronary heart disease and its relation to selected risk factorsOtto Mayer, Jaroslav Simon, Jan Filipovský, et al.
Vnitrni Lekarstvi|April 18, 2023
Dosing of basic pharmacotherapy and its effect on the prognosis of patients hospitalized for heart failureTomáš Krynský, Otto Mayer, Jan Bruthans, et al.
Pageof 8